Buy Price: $8.00 or better Sell Price: TradersPro Sell Signal Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed […]
Read MorePlus, Novavax signed a deal with SK Bioscience to manufacture the antigen component of its COVID-19 vaccine candidate, Apple is reportedly preparing bundles of its digital services, and Tapestry shares are down after reporting earnings.
Read MoreThe market’s plunge from late February to March was perhaps the most rapid descent to bear market levels in history; the road back, while not as rapid, has also been remarkable, taking just about five months for the S&P 500 to follow the NASDAQ above its pre-pandemic highs, with the Dow Jones Industrial Average within […]
Read MoreTrade Setup Buy Target: $1.84 Sell Target: $2.22 Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic pain, and/or […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MorePlus, China wants TikTok and WeChat to be on the agenda in upcoming trade talks with the U.S., the U.S. government will purchase at least 100 million doses of Moderna’s coronavirus vaccine, and Stein Mart just became the latest retailer to declare bankruptcy.
Read MoreBuy Price: $106.00 or better Sell Price: TradersPro Sell Signal ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces in […]
Read MoreAs a value-focused investor with more than a bit of a contrarian bent, I tend to get nervous when stocks keep making one new high after another, and I like it when I see stocks trading at or near historical lows. That’s pretty different than the mindset of most investors that focus on growth first, […]
Read MorePlus, Russia’s Putin claims the country has approved the world’s first coronavirus vaccine, Boeing said cancellations outpaced new sales for the sixth straight month in July, and Nikola shares surged after landing a garbage trucks deal.
Read MoreThe “herd mentality” can be a funny thing to think about in societal terms – but it’s a real thing in the stock market. The sheer number of publicly traded stocks on U.S. exchanges alone creates a wave of market data that no single person can handle alone, and that’s a big reason why it […]
Read MoreTrade Setup Buy Target – $39.62 Sell Target – $46.81 Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MorePlus, Treasury Secretary Mnuchin said the Trump administration is open to resuming talks with Democratic leaders on a new coronavirus relief bill as cases in the U.S. surpass 5 million, and Amazon is in discussions to take over old JCPenney and Sears stores to convert them into Amazon fulfillment centers.
Read MoreBuy Price: $63.00 or better Sell Price: TradersPro Sell Signal Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases. The company engages in the discovery and development of RNA medicines, including the production of RNA drug substance and nanoparticle-formulated drug product; and development of infectious disease […]
Read MoreOne of the biggest questions value-oriented investors have to ask themselves is the reason a stock may look like a good bargain. More often than not, one of the simplest reasons is because the stock has been beaten down by the broad market. The reasons for the decline can be multitudinous, and can imply any […]
Read More